- Home
- NPFD vs DNA Comparison
NPFD vs DNA Comparison
Compare NPFD & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPFD
- DNA
- Stock Information
- Founded
- NPFD 2021
- DNA 2008
- Country
- NPFD United States
- DNA United States
- Employees
- NPFD N/A
- DNA N/A
- Industry
- NPFD Trusts Except Educational Religious and Charitable
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NPFD Finance
- DNA Health Care
- Exchange
- NPFD Nasdaq
- DNA Nasdaq
- Market Cap
- NPFD 466.1M
- DNA 542.6M
- IPO Year
- NPFD N/A
- DNA N/A
- Fundamental
- Price
- NPFD $18.51
- DNA $10.10
- Analyst Decision
- NPFD
- DNA Hold
- Analyst Count
- NPFD 0
- DNA 6
- Target Price
- NPFD N/A
- DNA $37.80
- AVG Volume (30 Days)
- NPFD 64.7K
- DNA 1.5M
- Earning Date
- NPFD 01-01-0001
- DNA 11-12-2024
- Dividend Yield
- NPFD 6.28%
- DNA N/A
- EPS Growth
- NPFD N/A
- DNA N/A
- EPS
- NPFD N/A
- DNA N/A
- Revenue
- NPFD N/A
- DNA $217,951,000.00
- Revenue This Year
- NPFD N/A
- DNA N/A
- Revenue Next Year
- NPFD N/A
- DNA N/A
- P/E Ratio
- NPFD N/A
- DNA N/A
- Revenue Growth
- NPFD N/A
- DNA N/A
- 52 Week Low
- NPFD $14.50
- DNA $5.26
- 52 Week High
- NPFD $18.07
- DNA $74.00
- Technical
- Relative Strength Index (RSI)
- NPFD 32.82
- DNA 56.46
- Support Level
- NPFD $19.11
- DNA $10.48
- Resistance Level
- NPFD $19.43
- DNA $9.92
- Average True Range (ATR)
- NPFD 0.17
- DNA 1.14
- MACD
- NPFD -0.08
- DNA -0.12
- Stochastic Oscillator
- NPFD 3.15
- DNA 47.49
About NPFD Nuveen Variable Rate Preferred & Income Fund
Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.